Participants with hyperglycemia experienced a significantly attenuated reduction in weight over each log-month of follow-up compared to those without hyperglycemia (interaction estimate = +1.15, 95% CI: 0.741.55
All statements on this website, other than statements of historical fact, are forward-looking statements
doi:10.20945/2359-3997000000066
Dodd RD, Lee CL, Overton T, Huang W, Eward WC, Luo L, et al
PEG-MGF (pegylated mechano growth factor) is a synthetic peptide corresponding to the C-terminal E-domain of mechano growth factor (MGF), a splice variant of insulin-like growth factor-1 (IGF-1, designated IGF-1Ec)
Molecular mechanisms linking oxidative stress and diabetes mellitus